CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Head of Global Product Strat. gave up 244 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 122 shares (to pay taxes)
- 4 Planned sale Head of Development sold 81 shares at $282.87 ($22,912)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 4 Grant or award Director acquired 960 shares (grant or award)
- 4 Grant or award Director acquired 960 shares (grant or award)
- 4 Grant or award Director acquired 960 shares (grant or award)
- 4 Grant or award Director acquired 960 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 960 shares (grant or award)
- 4 Grant or award Director acquired 960 shares (grant or award)
- 4 Grant or award Director acquired 1,580 shares (grant or award)
- DEFA14A Proxy Proxy Materials
- DEFR14A Other DEFR14A
- DEFA14A Proxy Proxy Materials
Page 14 of 137 · 2,721 filings